Skip to main content

Advertisement

Log in

Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

Non-suppressive or partially suppressive L-T4 treatment demonstrated to be effective in reducing the volume of the nodules. However, studies with long follow-up are lacking and significant controversy exists regarding the efficacy of non-suppressive L-T4 treatment in benign nodular goiter.

Aim

The goal of this study was to determine the evolution of thyroid nodules in subjects treated with a non-suppressive levothyroxine (L-T4) dose, compared to untreated subjects.

Design and patients

We followed for a period of 1–9 years the thyroid nodule size in 356 female patients in the age range 19–45 at study entry, of which 201 untreated (Group 0) and 165 treated with a non-suppressive L-T4 dose (Group L-T4).

Measurements

We determined the volume of thyroid nodules by ultrasonography.

Results

The initial mean nodule volume in Group 0 and Group L-T4 was 3.91 ± 6.87 and 4.01 ± 7.35 mL, respectively. Nodule volume increase was inversely correlated to the initial volume. The final volume was slightly higher in untreated than in L-T4 treated subjects (5.37 ± 8.49 and 4.39 ± 6.72 mL). In both groups, the mean of annual fold increase of nodule volume was inversely correlated with the follow-up duration (P < 0.0046), indicating a slower growth as time advances. In the subjects treated with L-T4, the mean annual increase of nodule volume was significantly minor compared to untreated subjects. Concomitant nodules in ten multinodular goiters exhibited totally independent evolution, demonstrating that intranodular factors are more important for the nodule behavior than extra nodular factors.

Conclusions

Our study demonstrates that the growth of benign thyroid nodules is inversely correlated to their size, benign nodules naturally growth slowly as time advances, and that a chronic treatment with L-T4 at a non-TSH-suppressive dose significantly reduces their growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493

    Article  CAS  Google Scholar 

  2. Tonacchera M, Pinchera A, Vitti P (2010) Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab 24:51–61

    Article  CAS  PubMed  Google Scholar 

  3. Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840

    Article  CAS  PubMed  Google Scholar 

  4. Astwood EB, Cassidy CE, Aurbach GD (1960) Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459–464

    Article  CAS  PubMed  Google Scholar 

  5. Shimaoka K, Sokal JE (1974) Suppressive therapy of nontoxic goiter. Am J Med 57:576–583

    Article  CAS  PubMed  Google Scholar 

  6. La Rosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8

    Article  PubMed  Google Scholar 

  7. Lima N, Knobel M, Cavaliere H et al (1997) Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691–697

    Article  CAS  PubMed  Google Scholar 

  8. Zelmanovitz F, Genro S, Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881–3885

    CAS  PubMed  Google Scholar 

  9. Gharib H, James EM, Charboneau JW et al (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75

    Article  CAS  PubMed  Google Scholar 

  10. Cheung PS, Lee JM, Boey JH (1989) Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 13:818–821

    Article  CAS  PubMed  Google Scholar 

  11. Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28

    Article  CAS  Google Scholar 

  12. Larijani B, Pajouhi M, Bastanhagh MH et al (1999) Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial. Endocr Pract 5:251–256

    Article  CAS  PubMed  Google Scholar 

  13. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M (1994) Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495–498

    Article  CAS  PubMed  Google Scholar 

  14. Papini E, Petrucci L, Guglielmi R et al (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783

    Article  CAS  PubMed  Google Scholar 

  15. Uzzan B, Campos J, Cucherat M et al (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289

    CAS  PubMed  Google Scholar 

  16. Koc M, Ersoz HO, Akpinar I et al (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628

    Article  CAS  Google Scholar 

  17. Grussendorf M, Reiners C, Paschke R, Wegscheider K (2012) Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 96:2786–2795

    Article  Google Scholar 

  18. Fine-needle aspiration cytology (FNAC). Guidelines for the management of thyroid cancer. 2nd edition. Royal College of Physicians, London: Perros: 9-10

  19. Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68

    Article  CAS  Google Scholar 

  20. Kuma K, Matsuzuka F, Kobayashi A et al (1992) Outcome of long standing solitary thyroid nodules. World J Surg 16:583–587

    Article  CAS  PubMed  Google Scholar 

  21. Knudsen N, Bulow I, Laurberg P et al (2002) Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol (Oxf) 57:71–76

    Article  CAS  Google Scholar 

  22. Knudsen N, Bulow I, Laurberg P et al (2001) Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf) 55:41–46

    Article  CAS  Google Scholar 

  23. Kristensen HL, Vadstrup S, Knudsen N, Siersbaek-Nielsen K (1995) Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake. J Endocrinol Invest 18:41–43

    Article  CAS  PubMed  Google Scholar 

  24. Hegedus L, Rasmussen N, Ravn V et al (1988) Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism 37:229–233

    Article  CAS  PubMed  Google Scholar 

  25. Knudsen N, Bulow I, Laurberg P et al (2002) Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Eur J Endocrinol 146:39–43

    Article  CAS  PubMed  Google Scholar 

  26. Sapio MR, Guerra A, Marotta V et al (2011) High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab 96:E916–E919

    Article  CAS  PubMed  Google Scholar 

  27. Marotta V, Guerra A, Sapio MR et al (2010) Growing thyroid nodules with benign histology and RET rearrangement. Endocr J 57:1081–1087

    Article  PubMed  Google Scholar 

  28. Marotta V, Guerra A, Sapio MR et al (2010) Are RET/PTC rearrangements in benign thyroid nodules of biological significance? Thyroid 20:1191–1192

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Vitale.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Puzziello, A., Carrano, M., Angrisani, E. et al. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. J Endocrinol Invest 37, 1181–1186 (2014). https://doi.org/10.1007/s40618-014-0128-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-014-0128-z

Keyterms

Navigation